These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36731946)

  • 1. Flecainide toxicity: ECG changes associated with supratherapeutic levels in milk-fed infants.
    Bhatt H; Regan W; Rosenthal E; Bellsham-Revell H
    BMJ Case Rep; 2023 Feb; 16(2):. PubMed ID: 36731946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric flecainide toxicity from a double dose.
    Close BR; Banks CJ
    Am J Emerg Med; 2012 Nov; 30(9):2095.e1-2. PubMed ID: 22386360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal ECG changes caused by supratherapeutic flecainide following treatment for fetal supraventricular tachycardia.
    Rasheed A; Simpson J; Rosenthal E
    Heart; 2003 Apr; 89(4):470. PubMed ID: 12639886
    [No Abstract]   [Full Text] [Related]  

  • 4. When potion becomes poison! A case report of flecainide toxicity.
    Bajaj S; Tullu MS; Khan Z; Agrawal M
    J Postgrad Med; 2017; 63(4):265-267. PubMed ID: 28272074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased milk drinking causing flecainide toxicity in an older child.
    Thompson B; Mangat J; Barton C; Hawcutt DB
    BMJ Case Rep; 2012 Jun; 2012():. PubMed ID: 22729333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flecainide: its proarrhythmic effect and expected changes on the surface electrocardiogram.
    Morganroth J; Horowitz LN
    Am J Cardiol; 1984 Feb; 53(5):89B-94B. PubMed ID: 6695821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flecainide acetate for treatment of tachyarrhythmias in children: review of world literature on efficacy, safety, and dosing.
    Perry JC; Garson A
    Am Heart J; 1992 Dec; 124(6):1614-21. PubMed ID: 1462922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flecainide acetate: concentration-response relationships for antiarrhythmic and electrocardiographic effects.
    Boriani G; Capucci A; Strocchi E; Calliva R; Santarelli A; Biffi M; Magnani B
    Int J Clin Pharmacol Res; 1993; 13(4):211-9. PubMed ID: 8150547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flecainide administration in children: dosage, drug levels, and clinical effect.
    Thomas SAL; Ferguson R; Wilson DG
    Cardiol Young; 2023 Oct; 33(10):2072-2077. PubMed ID: 36546365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brugada pattern masquerading as ST-segment elevation myocardial infarction in flecainide toxicity.
    Chhabra L; Spodick DH
    Indian Heart J; 2012; 64(4):404-7. PubMed ID: 22929826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrhythmogenic effect of flecainide toxicity.
    Courand PY; Sibellas F; Ranc S; Mullier A; Kirkorian G; Bonnefoy E
    Cardiol J; 2013; 20(2):203-5. PubMed ID: 23558880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proarrhythmic effects of the new antiarrhythmic agent flecainide acetate.
    Nathan AW; Hellestrand KJ; Bexton RS; Banim SO; Spurrell RA; Camm AJ
    Am Heart J; 1984 Feb; 107(2):222-8. PubMed ID: 6695656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent electrocardiographic changes after flecainide overdose.
    Greig J; Groden BM
    Br J Clin Pract; 1995; 49(4):218-9. PubMed ID: 7547168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How are arrhythmias managed in the paediatric population in Europe? Results of the European Heart Rhythm survey.
    Hernández-Madrid A; Hocini M; Chen J; Potpara T; Pison L; Blomström-Lundqvist C;
    Europace; 2014 Dec; 16(12):1852-6. PubMed ID: 25417228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ECG diagnosis: flecainide toxicity.
    Levis JT
    Perm J; 2012; 16(4):53. PubMed ID: 23251119
    [No Abstract]   [Full Text] [Related]  

  • 16. [Flecainide: a new antiarrhythmic agent].
    Leclercq JF; Coumel P
    Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1218-30. PubMed ID: 6418100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proarrhythmic effects of flecainide.
    Nathan AW; Hellestrand KJ; Bexton RS; Spurrell RA; Camm AJ
    Drugs; 1985; 29 Suppl 4():45-53. PubMed ID: 4006779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short QT syndrome: pharmacological treatment.
    Gaita F; Giustetto C; Bianchi F; Schimpf R; Haissaguerre M; Calò L; Brugada R; Antzelevitch C; Borggrefe M; Wolpert C
    J Am Coll Cardiol; 2004 Apr; 43(8):1494-9. PubMed ID: 15093889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proarrhythmic Effects Of Antiarrhythmic Drugs: Case Study Of Flecainide Induced Ventricular Arrhythmias During Treatment Of Atrial Fibrillation.
    Barman M
    J Atr Fibrillation; 2015 Dec; 8(4):1091. PubMed ID: 27957216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.